Pharnext

USPTO Trademark & Patent Filings

Trademark applications and grants for Pharnext. Pharnext has 19 trademark applications. The latest application filed is for "ZINGITY"

Company Profile

PHARNEXT
pharnext
PHARNEXT - Paris FR
Pharnext - Paris FR
PHARNEXT - ISSY LES MOULINEAUX FR
Pharnext - Issy-les-Moulineaux FR
Pharnext - Issy les Moulineaux N/A FR
PHARNEXT - Issy les Moulineaux FR

Trademarks Patents

Patent Applications

Patent Application	Date
COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS 20210322402 - 17/132547 COHEN; Daniel ; et al.	2021-10-21
EARLY TREATMENT OF CMT DISEASE 20210260053 - 17/194703 Cohen; Daniel ; et al.	2021-08-26
BACLOFEN AND ACAMPROSATE BASED THERAPY OF ALZHEIMER'S DISEASE IN PATIENTS HAVING LOST RESPONSIVENESS TO ACETYLCHOLINESTERASE INHIBITOR THERAPY 20210236445 - 16/965310 BRUREAU; ANTHONY ; et al.	2021-08-05
THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS 20210069135 - 16/950489 Cohen; Daniel ; et al.	2021-03-11
METHOD FOR ADAPTING DOSES OF COMBINATION THERAPIES 20200306211 - 15/779750 Cohen; Daniel ; et al.	2020-10-01
Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis 11,291,670 - 12/915,709 Cohen , et al. April 5, 2	2022-04-05
Early treatment of CMT disease 10,940,147 - 16/505,000 Cohen , et al. March 9, 2	2021-03-09
Early treatment of CMT disease 10,940,147 - 16/505,000 Cohen , et al. March 9, 2	2021-03-09
Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders 10,905,672 - 15/117,774 Cohen , et al. February 2, 2	2021-02-02
Compositions for treating CMT and related disorders 10,905,686 - 15/969,568 Cohen , et al. February 2, 2	2021-02-02

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"ZINGITY" 79328603	ZINGITY 2021-11-03
"CINGILVIA" 79328945	CINGILVIA 2021-11-03
"PHARNEXT" 79316694	PHARNEXT 2021-03-01
"PHARNEXT" 88424864	PHARNEXT 2019-05-10
"SYNGILVIA" 79247832	SYNGILVIA 2018-10-30
"ORPHANEXT" 79238743	ORPHANEXT 2018-03-09
"XIEMTI" 79225739	XIEMTI 2017-11-14
"PLEOTHERAPY" 79225505	PLEOTHERAPY 2017-11-07
"Symbol/Image" 5572714 79224918	Symbol/Image 2017-11-02
"SYNGILITY" 5442375 87507411	SYNGILITY 2017-06-27
"PLEOTREATMENT" 4661507 79142345	PLEOTREATMENT 2013-09-04
"PHARNEXT" 4611799 79137568	PHARNEXT 2013-06-20
"PLEODIAL" 4594886 79134518	PLEODIAL 2013-06-20
"PLEOMOLECULE" 3835164 79063911	PLEOMOLECULE 2008-10-10
"PLEOMEDICAMENT" 3835165 79063912	PLEOMEDICAMENT 2008-10-10
"PLEOME" 3835166 79063913	PLEOME 2008-10-10
"PLEODRUG" 3835167 79063914	PLEODRUG 2008-10-10
"PLEOTHERAPIE" 3835168 79063915	PLEOTHERAPIE 2008-10-10
"PHARNEXT" 3835163 79063910	PHARNEXT 2008-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.